Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Surgery Partners CS (SGRY)

Surgery Partners CS (SGRY)
18.00 x 1 24.27 x 1
Post-market by (Cboe BZX)
21.22 +0.13 (+0.62%) 04/17/25 [NASDAQ]
18.00 x 1 24.27 x 1
Post-market 21.22 unch (unch) 16:07 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
21.05
Day High
21.59
Open 21.50
Previous Close 21.09 21.09
Volume 627,500 627,500
Avg Vol 995,170 995,170
Stochastic %K 34.39% 34.39%
Weighted Alpha -18.30 -18.30
5-Day Change +0.35 (+1.68%) +0.35 (+1.68%)
52-Week Range 19.50 - 33.97 19.50 - 33.97
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,707,948
  • Shares Outstanding, K 127,613
  • Annual Sales, $ 3,114 M
  • Annual Income, $ -168,100 K
  • EBIT $ 462 M
  • EBITDA $ 615 M
  • 60-Month Beta 2.40
  • Price/Sales 0.86
  • Price/Cash Flow 11.26
  • Price/Book 0.84

Options Overview Details

View History
  • Implied Volatility 53.60% ( -16.52%)
  • Historical Volatility 32.34%
  • IV Percentile 33%
  • IV Rank 33.18%
  • IV High 100.99% on 04/07/25
  • IV Low 30.07% on 03/07/25
  • Put/Call Vol Ratio 0.63
  • Today's Volume 3,863
  • Volume Avg (30-Day) 1,037
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 41,168
  • Open Int (30-Day) 34,612

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year 0.06
  • Growth Rate Est. (year over year) -166.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.50 +8.82%
on 04/07/25
Period Open: 24.40
24.60 -13.74%
on 03/26/25
-3.18 (-13.03%)
since 03/17/25
3-Month
19.50 +8.82%
on 04/07/25
Period Open: 20.19
26.16 -18.88%
on 02/14/25
+1.03 (+5.10%)
since 01/17/25
52-Week
19.50 +8.82%
on 04/07/25
Period Open: 24.47
33.97 -37.53%
on 08/26/24
-3.25 (-13.28%)
since 04/17/24

Most Recent Stories

More News
Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details

SGRY : 21.22 (+0.62%)
Outpatient & Specialty Care Stocks Q4 Teardown: Encompass Health (NYSE:EHC) Vs The Rest

Outpatient & Specialty Care Stocks Q4 Teardown: Encompass Health (NYSE:EHC) Vs The Rest

EHC : 103.35 (+0.34%)
USPH : 67.45 (-1.46%)
AGL : 4.00 (-26.87%)
LFST : 6.70 (-0.15%)
SGRY : 21.22 (+0.62%)
Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest

Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest

EHC : 103.35 (+0.34%)
AGL : 4.00 (-26.87%)
LFST : 6.70 (-0.15%)
SEM : 16.36 (+0.18%)
SGRY : 21.22 (+0.62%)
Q4 Earnings Outperformers: DaVita (NYSE:DVA) And The Rest Of The Outpatient & Specialty Care Stocks

Q4 Earnings Outperformers: DaVita (NYSE:DVA) And The Rest Of The Outpatient & Specialty Care Stocks

USPH : 67.45 (-1.46%)
AGL : 4.00 (-26.87%)
LFST : 6.70 (-0.15%)
SGRY : 21.22 (+0.62%)
DVA : 140.03 (-1.04%)
3 Reasons SGRY is Risky and 1 Stock to Buy Instead

3 Reasons SGRY is Risky and 1 Stock to Buy Instead

COST : 994.50 (+2.76%)
SGRY : 21.22 (+0.62%)
Q4 Earnings Highs And Lows: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks

Q4 Earnings Highs And Lows: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks

AGL : 4.00 (-26.87%)
LFST : 6.70 (-0.15%)
SEM : 16.36 (+0.18%)
SGRY : 21.22 (+0.62%)
DVA : 140.03 (-1.04%)
Surgery Partners: Q4 Earnings Snapshot

Surgery Partners: Q4 Earnings Snapshot

SGRY : 21.22 (+0.62%)
Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations

Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations

SGRY : 21.22 (+0.62%)
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance

SGRY : 21.22 (+0.62%)
Surgery Partners (SGRY) Q4 Earnings Report Preview: What To Look For

Surgery Partners (SGRY) Q4 Earnings Report Preview: What To Look For

EHC : 103.35 (+0.34%)
LFST : 6.70 (-0.15%)
SGRY : 21.22 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment...

See More

Key Turning Points

3rd Resistance Point 22.06
2nd Resistance Point 21.83
1st Resistance Point 21.52
Last Price 21.22
1st Support Level 20.98
2nd Support Level 20.75
3rd Support Level 20.44

See More

52-Week High 33.97
Fibonacci 61.8% 28.44
Fibonacci 50% 26.74
Fibonacci 38.2% 25.03
Last Price 21.22
52-Week Low 19.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro